1. From the Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA; the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; the Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and the CLL Research Consortium, University of California, San Diego.